Literature DB >> 7635941

The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).

M W Mosesson1, K R Siebenlist, J P DiOrio, M Matsuda, J F Hainfeld, J S Wall.   

Abstract

Intermolecular end-to-middle domain pairing between a thrombin-exposed 'A' polymerization site in the central 'E' domain of fibrin, and a constitutive complementary 'a' site in each outer 'D' domain ('D:E'), is necessary but not alone sufficient for normal fibrin assembly, as judged from previous studies of a congenital dysfibrinogen, Tokyo II (gamma 275 arg-->cys), which showed defective fibrin clot assembly and a normal D:E interaction (Matsuda, M., M. Baba, K. Morimoto, and C. Nakamikawa, 1983. J. Clin. Invest. 72:1034-1041). In addition to the 'a' polymerization site, two other constitutive intermolecular association sites on fibrinogen D domains have been defined: between gamma chain regions containing the carboxy-terminal factor XIIIa crosslinking site ('gamma XL:gamma XL'); and between sites located at the outer ends of each molecule ('D:D') (Mosesson, M. W., K. R. Siebenlist, J. F. Hainfeld, and J. S. Wall, manuscript submitted for publication). We evaluated the function of these sites in Tokyo II fibrinogen, and confirmed that there was a normal fibrin D:E interaction, as determined from a normal fibrin crosslinking rate in the presence of factor XIIIa. We also found a normal gamma XL: gamma XL interaction, as assessed by a normal fibrinogen crosslinking rate. Judging from electron microscopic images, factor XIIIa-crosslinked Tokyo II fibrinogen failed to form elongated double-stranded fibrils like normal fibrinogen. Instead, it formed aggregated disordered collections of molecules, with occasional short fibrillar segments. In addition, Tokyo II fibrin formed an abnormal, extensively branched clot network containing many tapered terminating fibers. These findings indicate that the Tokyo II fibrinogen defect results in a functionally abnormal D:D self-association site, and that a normal D:D site interaction is required, in addition to D:E, for normal fibrin or fibrinogen assembly.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635941      PMCID: PMC185294          DOI: 10.1172/JCI118091

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Fibrin assembly.

Authors:  R Hantgan; J McDonagh; J Hermans
Journal:  Ann N Y Acad Sci       Date:  1983-06-27       Impact factor: 5.691

2.  Fibrinogen Birmingham: a heterozygous dysfibrinogenemia (A alpha 16 Arg----His) containing heterodimeric molecules.

Authors:  K R Siebenlist; J T Prchal; M W Mosesson
Journal:  Blood       Date:  1988-03       Impact factor: 22.113

3.  Fibrinogen Detroit - an abnormal fibrinogen with non-functinal NH2-terminal polymerization domain.

Authors:  B Kudryk; B Blombäck; M Blombäck
Journal:  Thromb Res       Date:  1976-07       Impact factor: 3.944

4.  Evidence for a second type of fibril branch point in fibrin polymer networks, the trimolecular junction.

Authors:  M W Mosesson; J P DiOrio; K R Siebenlist; J S Wall; J F Hainfeld
Journal:  Blood       Date:  1993-09-01       Impact factor: 22.113

5.  Evidence for four different polymerization sites involved in human fibrin formation.

Authors:  S A Olexa; A Z Budzynski
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

6.  Physiological studies on fibrin network structure.

Authors:  G A Shah; C H Nair; D P Dhall
Journal:  Thromb Res       Date:  1985-10-15       Impact factor: 3.944

7.  Morphology of bovine fibrinogen monomers and fibrin oligomers.

Authors:  R C Williams
Journal:  J Mol Biol       Date:  1981-08-15       Impact factor: 5.469

8.  Relations between enzymatic and association reactions in the development of bovine fibrin clot structure.

Authors:  J K Wolfe; D F Waugh
Journal:  Arch Biochem Biophys       Date:  1981-10-01       Impact factor: 4.013

9.  The preparation and properties of human fibrinogen of relatively high solubility.

Authors:  M W Mosesson; S Sherry
Journal:  Biochemistry       Date:  1966-09       Impact factor: 3.162

10.  Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution.

Authors:  C Steinmann; C Bögli; M Jungo; B Lämmle; G Heinemann; B Wermuth; R Redaelli; F Baudo; M Furlan
Journal:  Blood Coagul Fibrinolysis       Date:  1994-08       Impact factor: 1.276

View more
  12 in total

1.  Polymerization of rod-like macromolecular monomers studied by stopped-flow, multiangle light scattering: set-up, data processing, and application to fibrin formation.

Authors:  S Bernocco; F Ferri; A Profumo; C Cuniberti; M Rocco
Journal:  Biophys J       Date:  2000-07       Impact factor: 4.033

2.  Nanoscale probing reveals that reduced stiffness of clots from fibrinogen lacking 42 N-terminal Bbeta-chain residues is due to the formation of abnormal oligomers.

Authors:  Radwa H Abou-Saleh; Simon D Connell; Robert Harrand; Ramzi A Ajjan; Michael W Mosesson; D Alastair M Smith; Peter J Grant; Robert A S Ariëns
Journal:  Biophys J       Date:  2009-03-18       Impact factor: 4.033

3.  The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the "Dusart syndrome".

Authors:  M W Mosesson; K R Siebenlist; J f Hainfeld; J S Wall; J Soria; C Soria; J P Caen
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

4.  Severe bleeding in a woman heterozygous for the fibrinogen gammaR275C mutation.

Authors:  Chantelle M Rein; Brian L Anderson; Morgan M Ballard; Christopher M Domes; Joshua M Johnston; Russell Jared Madsen; Kathryn K M Wolper; Andrew S Terker; John M Strother; Thomas G Deloughery; David H Farrell
Journal:  Blood Coagul Fibrinolysis       Date:  2010-07       Impact factor: 1.276

5.  The strengthening role of D:D interactions in fibrin self-assembly under oxidation.

Authors:  M A Rosenfeld; V B Leonova; A V Bychkova; E A Kostanova; M I Biryukova; N B Sultimova; M L Konstantinova; M G Gorobets
Journal:  Dokl Biochem Biophys       Date:  2016-03-31       Impact factor: 0.788

Review 6.  Structure and function of human fibrinogen inferred from dysfibrinogens.

Authors:  Michio Matsuda; Teruko Sugo
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

7.  The location of the carboxy-terminal region of gamma chains in fibrinogen and fibrin D domains.

Authors:  M W Mosesson; K R Siebenlist; D A Meh; J S Wall; J F Hainfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

8.  Fibrinogen nanofibril growth and self-assembly on Au (1,1,1) surface in the absence of thrombin.

Authors:  Guojun Chen; Nanting Ni; Binghe Wang; Bingqian Xu
Journal:  Chemphyschem       Date:  2010-02-22       Impact factor: 3.102

9.  Fibrinogen Hershey IV: a novel dysfibrinogen with a gammaV411I mutation in the integrin alpha(IIb)beta(3) binding site.

Authors:  Veronica H Flood; Hamid A Al-Mondhiry; Chantelle M Rein; Kristine S Alexander; Rehana S Lovely; Kelley M Shackleton; Larry L David; David H Farrell
Journal:  Thromb Haemost       Date:  2008-06       Impact factor: 5.249

10.  Mutations Causing Mild or No Structural Damage in Interfaces of Multimerization of the Fibrinogen γ-Module More Likely Confer Negative Dominant Behaviors.

Authors:  Emanuele Bellacchio
Journal:  Int J Mol Sci       Date:  2020-11-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.